Fluphenazine (Prolixin)

What it treats

Fluphenazine is FDA-approved for schizophrenia and other psychotic disorders. Its long-acting injectable form is one of the reasons it stays in regular use. When someone struggles to take a daily pill, a monthly or twice-monthly injection can be the difference between staying well and relapsing. It isn't generally a first choice for new-start schizophrenia today because of movement side effects, but it remains an important option when adherence, cost, or prior response points toward it.

How it works

Fluphenazine is a first-generation antipsychotic that works by blocking dopamine at the D2 receptor. Dopamine overactivity in certain brain circuits is thought to drive hallucinations, delusions, and disorganized thinking, and blocking D2 quiets that signaling. Unlike the low-potency phenothiazines, fluphenazine has relatively little activity at histamine, muscarinic, or alpha-adrenergic receptors, so it doesn't cause as much sedation or blood pressure drop but does cause more prominent movement effects.

Receptor mechanism (detail)

Fluphenazine is a high-potency D2 antagonist with minimal H1, muscarinic, or alpha-1 activity. The clean D2 profile is what makes it high-potency: small milligram doses do meaningful work. The trade-off is a higher rate of extrapyramidal side effects (parkinsonism, akathisia, acute dystonia) and higher long-term risk of tardive dyskinesia compared with atypical antipsychotics. Fluphenazine also raises prolactin.

Potency and typical dosing pattern

Ranges are typical framework only, not a prescription for any individual. Fluphenazine is high-potency, so the milligram numbers are small.

For oral maintenance, a common range is 2.5 to 10 mg per day, sometimes higher in acute treatment. For the long-acting injection, fluphenazine decanoate is typically 12.5 to 50 mg intramuscularly every 2 to 4 weeks, given by a clinician. The oral concentrate is useful when swallowing tablets is a barrier. The prescriber sets and adjusts the dose based on response, side effects, and other medications.

Safety monitoring

• Involuntary-movement screen (AIMS) every six months for tardive dyskinesia.
• Movement side-effect check at every early visit, stiffness, tremor, restlessness.
• Prolactin if symptoms appear, breast changes, milk production, or menstrual changes.
• Metabolic labs, weight, BMI, fasting glucose or HbA1c, and lipids at baseline and annually. Metabolic effects tend to be light.
• Blood pressure at baseline and periodically.
• Liver function at baseline and if symptoms suggest it.

Metformin co-commencement: Aoife Carolan / Schizophrenia Bulletin guideline.

A clinical guideline led by Aoife Carolan strongly recommends co-commencing metformin alongside high-risk antipsychotics like olanzapine or clozapine. This proactive approach helps mitigate severe metabolic side effects, significantly reducing antipsychotic-induced weight gain and improving insulin resistance. The Schizophrenia Bulletin guideline states that when prescribing olanzapine or clozapine, metformin should be initiated immediately to prevent weight gain and cardiometabolic issues. Fluphenazine is a first-generation antipsychotic and isn't on the automatic co-commencement list, but metformin is recommended if weight rises more than 3 percent of pre-medication weight or if other cardiometabolic risk factors are present.

Typical titration used in the guideline: 500 mg once daily, then 500 mg twice daily after one week, then 500 mg increments every two weeks as tolerated, up to 1000 mg twice daily by about week six. Contraindicated with eGFR below 30 mL/min/1.73 m². Renal function is checked annually and metformin is held during acute illness or dehydration.

Source: Carolan A, et al. Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus Validation. Schizophrenia Bulletin. 2025;51(5):1193 to 1203.

What to expect

Common side effects

• Parkinsonism, stiffness, slowness, tremor.
• Akathisia, restlessness and inability to sit still.
• Acute dystonia, sudden painful muscle spasms.
• Raised prolactin, breast changes, milk production, menstrual changes.
• Mild sedation.
• Dry mouth (less than with chlorpromazine).

Serious side effects and warnings

Boxed warning. Fluphenazine carries the FDA boxed warning that antipsychotics increase the risk of death in older adults with dementia-related psychosis, and it isn't approved for that use.

• Tardive dyskinesia. Risk rises with dose and duration.
• Neuroleptic malignant syndrome. Rare but serious, high fever, muscle rigidity, confusion, autonomic instability. A medical emergency.
• Acute dystonic reactions. Treatable and usually reversible with a dose of diphenhydramine or benztropine.
• QTc prolongation at higher doses or with other QT drugs.
• Seizure threshold lowering, relevant in epilepsy.

This isn't medical advice. Any concern about a serious side effect should be raised with a prescriber promptly.

Sexual side effects

Fluphenazine can lower sex drive and cause erectile problems, delayed orgasm, or galactorrhea from raised prolactin. If sexual side effects appear, it's worth raising with the prescriber.

Weight, appetite, and sleep

Weight gain with fluphenazine tends to be smaller than with olanzapine or clozapine but can still happen. Sleep may be slightly disrupted in some people and unchanged in others. If sleep problems persist, that's worth raising.

Starting and dosing basics

This section is general background, not a dosing instruction. Fluphenazine comes as tablets, an oral concentrate, and a long-acting decanoate injection given every 2 to 4 weeks. The switch from oral to long-acting requires a period of overlap that the prescriber manages. It can be taken with or without food.

Missed doses and interactions

If you miss an oral dose, take it when you remember unless it's almost time for the next one, then skip and carry on. For the long-acting injection, the clinic tracks the schedule. Fluphenazine interacts with other antipsychotics, some antibiotics, and QT-prolonging drugs. The prescriber and pharmacist need a full list of medications and supplements. Alcohol worsens sedation.

Stopping and tapering

Don't stop fluphenazine abruptly. A prescriber can step the dose down gradually or, for the injection, allow it to fade out with careful monitoring.

Pregnancy and breastfeeding

Individual circumstances matter and the decision belongs with a clinician. Untreated psychosis carries its own risks in pregnancy, and fluphenazine passes into breast milk. Anyone who's pregnant, planning a pregnancy, or breastfeeding should talk it through with their prescriber. This isn't medical advice.

Cost and generic availability

Fluphenazine has been generic for decades. The oral form is inexpensive, and the decanoate injection is more expensive but still moderate. Most insurance plans cover it. The long-acting form is one reason it holds a niche in modern practice.

Common questions

Why choose the injection over the pill? The decanoate injection gives steady drug levels for 2 to 4 weeks at a time, which removes the daily-pill burden and reduces the chance of missed doses. For people who struggle to take pills consistently, this can be the difference between staying well and relapsing.

How does fluphenazine compare with haloperidol? Both are high-potency first-generation antipsychotics with similar side-effect patterns. Fluphenazine tends to be slightly more sedating and slightly less activating than haloperidol. The choice often comes down to clinical experience with the specific person and what long-acting formulation is available.

What's the risk of tardive dyskinesia? Real and cumulative. Long-term use of any first-generation antipsychotic carries a higher tardive dyskinesia risk than most atypicals. Regular AIMS screening catches it early when there are more treatment options.

Do I still need labs even though fluphenazine is metabolically light? Yes. Weight, glucose, and lipids still shift for some people, and periodic checks catch changes early.

Questions to ask your prescriber

• What are we hoping this treats, and how will we know it's working?
• Would a long-acting injection make sense for me?
• What movement side effects should I watch for?
• If I get restless or stiff, what should I do?
• If we decide to stop it later, how would we taper safely?

Sources

This guide draws on current prescribing information and public health references. It is reviewed for clinical accuracy and updated as guidance changes, and current as of June 8, 2026.

• U.S. Food and Drug Administration. Fluphenazine prescribing information.
• MedlinePlus, U.S. National Library of Medicine. Fluphenazine.
• National Institute of Mental Health. Mental health medications.
• American Psychiatric Association. Practice Guideline for the Treatment of Patients with Schizophrenia, 3rd edition.
• National Institute for Health and Care Excellence (NICE). CG178, Psychosis and schizophrenia in adults.
• Carolan A, et al. Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus Validation. Schizophrenia Bulletin. 2025;51(5):1193 to 1203.